Advertisement

Topics

Antimycotic Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation

2014-07-23 21:11:16 | BioPortfolio

Summary

Pediatric patients are at high risk to acquire mycotic infections following allogeneic bone marrow transplantation. In the present retrospective analysis we assess the safety and efficacy of different regimens in antimycotic prophylaxis.

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Conditions

Systemic Aspergillosis

Location

University Children's Hospital
Tuebingen
Germany
72076

Status

Completed

Source

University Children’s Hospital Tuebingen

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-07-23T21:11:16-0400

Clinical Trials [444 Associated Clinical Trials listed on BioPortfolio]

Micafungin Salvage Mono-therapy in Invasive Aspergillosis

To evaluate the efficacy and safety of micafungin in patients with proven invasive aspergillosis and who are refractory or intolerant to previous systemic antifungal therapy. To compare th...

Comparison of Voriconazole and Amphotericin B in Treating Patients With Aspergillosis

RATIONALE: Antifungal therapy with voriconazole or amphotericin B may be an effective treatment for aspergillosis. It is not yet known whether voriconazole is more effective than amphoteri...

Impact of Pre-existing Invasive Aspergillosis on Allogeneic Stem Cell Transplantation

We are planning to conduct a prospective non-interventional study. We would like to assess clinical outcome of patients with - and without - history of pre-existing invasive aspergillosis ...

Novel Biomarkers for Invasive Aspergillosis

Diagnosis of invasive aspergillosis remains difficult, and is often based on a combination of patient characteristics, radiological and microbiological findings. To data, galactomannan (GM...

VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in Adults

The purpose of the trial is to evaluate the safety and efficacy of a new antifungal with a novel mechanism of action in immunocompromised adults with invasive aspergillosis.

PubMed Articles [3075 Associated PubMed Articles listed on BioPortfolio]

Invasive tracheobronchial aspergillosis developed during radioimmunotherapy for malignant lymphoma.

Invasive pulmonary aspergillosis (IPA) often occurs during the treatment of malignant lymphoma. However, invasive tracheobronchial aspergillosis (ITBA) is a rare form of IPA. Particularly, due to the ...

Serum galactomannan antigen as a prognostic and diagnostic marker for invasive aspergillosis in heterogeneous medicine ICU patient population.

This study was conducted to get a complete clinical and mycological picture of invasive aspergillosis (IA) in respiratory medicine ICU of a tertiary care hospital.

Diagnosis of Invasive Aspergillosis in Hematological Malignancy Patients: Performance of Cytokines, Asp LFD, and Aspergillus PCR in Same Day Blood and Bronchoalveolar Lavage Samples.

Aspergillus spp. induce elevated levels of several cytokines. It remains unknown whether these cytokines hold value for clinical routine and enhance diagnostic performances of established and novel bi...

Voriconazole as mono-therapy in orbitofrontal erosive aspergillosis without gross total resection: A case report and review of literature.

In this case report we present an immunocompetent 64-year-old patient presenting with an orbitofrontal invasive aspergillosis treated successfully with voriconazole monotherapy following biopsy and or...

Sinonasal aspergillosis: Outcome after topical treatment in dogs with cribriform plate lysis.

Cribriform lysis has been considered a contraindication for topical treatment of sinonasal aspergillosis (SNA) because of concerns about drug extravasation with resultant neurologic signs or death.

Medical and Biotech [MESH] Definitions

Lung infections with the invasive forms of ASPERGILLUS, usually after surgery, transplantation, prolonged NEUTROPENIA or treatment with high-doses of CORTICOSTEROIDS. Invasive pulmonary aspergillosis can progress to CHRONIC NECROTIZING PULMONARY ASPERGILLOSIS or hematogenous spread to other organs.

Infections of the respiratory tract with fungi of the genus ASPERGILLUS. Infections may result in allergic reaction (ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS), colonization in pulmonary cavities as fungus balls (MYCETOMA), or lead to invasion of the lung parenchyma (INVASIVE PULMONARY ASPERGILLOSIS).

Infections with fungi of the genus ASPERGILLUS.

The sum of all nonspecific systemic reactions of the body to long-continued exposure to systemic stress.

One of the triazole ANTIFUNGAL AGENTS that inhibits cytochrome P-450-dependent enzymes resulting in impairment of ERGOSTEROL synthesis. It has been used against histoplasmosis, blastomycosis, cryptococcal meningitis & aspergillosis.

More From BioPortfolio on "Antimycotic Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pediatrics
Pediatrics is the general medicine of childhood. Because of the developmental processes (psychological and physical) of childhood, the involvement of parents, and the social management of conditions at home and at school, pediatrics is a specialty. With ...

Osteoporosis
Osteoporosis is a disease in which the bones become extremely porous, are subject to fracture, and heal slowly, occurring especially in women following menopause and often leading to curvature of the spine from vertebral collapse. Follow and track&n...

Transplantation
Organ transplantation is the moving of an organ from one body to another or from a donor site to another location on the patient's own body, for the purpose of replacing the recipient's damaged or absent organ. The emerging field of regenerative ...


Searches Linking to this Trial